Muckle-Wells Syndrome (MWS)

DBCOND0034417Congenital, Hereditary, and Neonatal Diseases and Abnormalitiesimmediate and delayed hypersensitivity reactions

Muckle-Wells Syndrome (MWS) is the indication for 2 drugs in DrugBank. It is covered by 2 curated, structured indications.

Also known as
Muckle Wells Syndrome · Muckle-Wells Syndrome · Muckle-wells Syn (MWS)
Classified under
Indicated drugs

Resolves to

Vocabularies
MeSHM0527983ICD-10M04.2SNOMED CT15123008MedDRA10064569UMLSC0268390

What you can answer from here — as of October 22, 2026

2Indicated drugsWith each drug's targets and mechanism
Listed above
2Structured indicationsPopulation, line of therapy, route and combination as fields, not prose
Sign in
9Clinical trialsPhase, status and sponsor resolved per trial
Sign in

Which approved drugs for Muckle-Wells Syndrome (MWS) share a target, and which companies have late-stage candidates against it?

Answer this in Biopharma OSSign in to your account

Create a free account or log in to explore the full data card.

Create Account
Log InPaid Account Log In